These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
974 related articles for article (PubMed ID: 16958996)
1. Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer. Takei H; Suemasu K; Kurosumi M; Horii Y; Ninomiya J; Yoshida M; Hagiwara Y; Inoue K; Tabei T Breast J; 2006; 12(5 Suppl 2):S157-64. PubMed ID: 16958996 [TBL] [Abstract][Full Text] [Related]
2. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection. Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151 [TBL] [Abstract][Full Text] [Related]
3. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968 [TBL] [Abstract][Full Text] [Related]
4. Impact of omission of axillary lymph node dissection after negative sentinel lymph node biopsy: 70-month follow-up. Kim HJ; Son BH; Lim WS; Seo JY; Koh BS; Lee JW; Gong GY; Ahn SH Ann Surg Oncol; 2010 Aug; 17(8):2126-31. PubMed ID: 20162458 [TBL] [Abstract][Full Text] [Related]
5. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer. Palesty JA; Foster JM; Hurd TC; Watroba N; Rezaishiraz H; Edge SB J Surg Oncol; 2006 Feb; 93(2):129-32. PubMed ID: 16425295 [TBL] [Abstract][Full Text] [Related]
6. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients? Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642 [TBL] [Abstract][Full Text] [Related]
7. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290 [TBL] [Abstract][Full Text] [Related]
8. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer. Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207 [TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients. Langer I; Guller U; Hsu-Schmitz SF; Ladewig A; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M Eur J Surg Oncol; 2009 Aug; 35(8):805-13. PubMed ID: 19046846 [TBL] [Abstract][Full Text] [Related]
10. Predictors of axillary lymph node metastases in women with early breast cancer in Singapore. Tan LG; Tan YY; Heng D; Chan MY Singapore Med J; 2005 Dec; 46(12):693-7. PubMed ID: 16308642 [TBL] [Abstract][Full Text] [Related]
11. Predictors to assess non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis. Jinno H; Sakata M; Asaga S; Wada M; Shimada T; Kitagawa Y; Suzuki T; Nakahara T; Kitamura N; Kubo A; Mukai M; Ikeda T; Kitajima M Breast J; 2008; 14(6):551-5. PubMed ID: 19000054 [TBL] [Abstract][Full Text] [Related]
12. Axillary lymph node dissection can be avoided in women with breast cancer with intraoperative, false-negative sentinel lymph node biopsies. Takei H; Kurosumi M; Yoshida T; Ishikawa Y; Hayashi Y; Ninomiya J; Tozuka K; Oba H; Inoue K; Nagai S; Saito Y; Kazumoto T; Saitoh J; Tabei T Breast Cancer; 2010; 17(1):9-16. PubMed ID: 19701679 [TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study. Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993 [TBL] [Abstract][Full Text] [Related]
14. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla? Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472 [TBL] [Abstract][Full Text] [Related]
15. Prognostic factors affecting survival and disease-free survival in lymph node-negative breast carcinomas. Kuru B; Camlibel M; Gulcelik MA; Alagol H J Surg Oncol; 2003 Jul; 83(3):167-72. PubMed ID: 12827686 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node. Rivers AK; Griffith KA; Hunt KK; Degnim AC; Sabel MS; Diehl KM; Cimmino VM; Chang AE; Lucas PC; Newman LA Ann Surg Oncol; 2006 Jan; 13(1):36-44. PubMed ID: 16378156 [TBL] [Abstract][Full Text] [Related]
17. Upstaging and improved survival of early breast cancer patients after implementation of sentinel node biopsy for axillary staging. Vanderveen KA; Schneider PD; Khatri VP; Goodnight JE; Bold RJ Ann Surg Oncol; 2006 Nov; 13(11):1450-6. PubMed ID: 17009150 [TBL] [Abstract][Full Text] [Related]
18. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years. Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841 [TBL] [Abstract][Full Text] [Related]
19. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial. Del Bianco P; Zavagno G; Burelli P; Scalco G; Barutta L; Carraro P; Pietrarota P; Meneghini G; Morbin T; Tacchetti G; Pecoraro P; Belardinelli V; De Salvo GL; Eur J Surg Oncol; 2008 May; 34(5):508-13. PubMed ID: 17614245 [TBL] [Abstract][Full Text] [Related]
20. Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure. Montagna E; Viale G; Rotmensz N; Maisonneuve P; Galimberti V; Luini A; Intra M; Veronesi P; Mazzarol G; Pruneri G; Renne G; Torrisi R; Cardillo A; Cancello G; Goldhirsch A; Colleoni M Breast Cancer Res Treat; 2009 Nov; 118(2):385-94. PubMed ID: 19562480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]